FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074550002> ?p ?o ?g. }

• W2074550002 endingPage "10" @default.
• W2074550002 startingPage "2" @default.
• W2074550002 abstract "To evaluate the effectiveness and morbidity of salvage brachytherapy for locally recurrent or persistent prostate cancer after radiotherapy failure.In this retrospective study, 49 patients of median age 73.3 years (range 52.9 to 86.9) with biopsy-proven localized prostate cancer underwent interactive transperineal fluoroscopic-guided and biplane ultrasound-guided brachytherapy with either iodine 125 or palladium 103 after prior radiotherapy failure. Post-treatment follow-up was conducted for a median of 64.1 months (range 26.6 to 96.8) and included clinical assessment of disease status, assays of serum prostate-specific antigen (PSA) levels, and documentation of treatment-related symptoms and complications. Determination of biochemical treatment failure was based on two successive rising PSA values above the post-treatment PSA nadir value.The actuarial rate of local prostate cancer control was 98% (95% confidence interval [CI] 94% to 99%). Actuarial disease-specific survival at 3 and 5 years was 89% (95% CI 73% to 96%) and 79% (95% CI 58% to 91%), respectively. At 3 and 5 years, actuarial biochemical disease-free survival was 48% (95% CI 32% to 63%) and 34% (95% CI 17% to 51%), respectively. Post-treatment PSA nadir was found to be a significant predictor of biochemical disease-free survival. Actuarial biochemical disease-free survival of patients who achieved a PSA nadir less than 0.5 ng/mL was 77% (95% CI 53% to 90%) and 56% (95% CI 25% to 78%) at 3 and 5 years, respectively. Of 49 patients, 23 (47%) achieved a post-treatment PSA nadir less than 0.5 ng/mL. The incidence of serious complications after salvage brachytherapy, such as incontinence and rectal complications, was lower than that reported after other types of salvage procedures.Interactive transperineal fluoroscopic-guided and biplane ultrasound-guided brachytherapy is a novel, potentially curative salvage modality for patients in whom prior radiotherapy failed. In a population of patients with poor prognosis, this modality was associated with a high rate of local prostate cancer control and a 34% actuarial rate of biochemical disease-free survival at 5 years. The incidence of major complications after salvage brachytherapy appears to be lower than that after other potentially curative salvage procedures, such as radical prostatectomy and cryoablation. Salvage brachytherapy warrants further investigation." @default.
• W2074550002 created "2016-06-24" @default.
• W2074550002 creator A5004249940 @default.
• W2074550002 creator A5007566100 @default.
• W2074550002 creator A5009179279 @default.
• W2074550002 creator A5014554150 @default.
• W2074550002 creator A5030172187 @default.
• W2074550002 creator A5031800910 @default.
• W2074550002 creator A5037441256 @default.
• W2074550002 creator A5047562050 @default.
• W2074550002 creator A5079008626 @default.
• W2074550002 date "1999-01-01" @default.
• W2074550002 modified "2023-09-25" @default.
• W2074550002 title "Salvage brachytherapy for localized prostate cancer after radiotherapy failure" @default.
• W2074550002 cites W1525744048 @default.
• W2074550002 cites W1834151937 @default.
• W2074550002 cites W1968774450 @default.
• W2074550002 cites W1969327970 @default.
• W2074550002 cites W1973245537 @default.
• W2074550002 cites W1974841849 @default.
• W2074550002 cites W1974964259 @default.
• W2074550002 cites W1974987635 @default.
• W2074550002 cites W1998732586 @default.
• W2074550002 cites W2012901998 @default.
• W2074550002 cites W2017076591 @default.
• W2074550002 cites W2028797451 @default.
• W2074550002 cites W2029631561 @default.
• W2074550002 cites W2033317825 @default.
• W2074550002 cites W2033848705 @default.
• W2074550002 cites W2042185237 @default.
• W2074550002 cites W2045109547 @default.
• W2074550002 cites W2045858226 @default.
• W2074550002 cites W2046548861 @default.
• W2074550002 cites W2048252655 @default.
• W2074550002 cites W2049259118 @default.
• W2074550002 cites W2053143980 @default.
• W2074550002 cites W2054307343 @default.
• W2074550002 cites W2056455567 @default.
• W2074550002 cites W2064057265 @default.
• W2074550002 cites W2064143800 @default.
• W2074550002 cites W2068539229 @default.
• W2074550002 cites W2074394448 @default.
• W2074550002 cites W2075817409 @default.
• W2074550002 cites W2087829832 @default.
• W2074550002 cites W2097771960 @default.
• W2074550002 cites W2105180850 @default.
• W2074550002 cites W2120328250 @default.
• W2074550002 cites W2150181583 @default.
• W2074550002 cites W2159943338 @default.
• W2074550002 cites W2167842599 @default.
• W2074550002 cites W2340534380 @default.
• W2074550002 cites W2395029142 @default.
• W2074550002 cites W2413190546 @default.
• W2074550002 cites W2415580910 @default.
• W2074550002 cites W2416276918 @default.
• W2074550002 cites W2416998459 @default.
• W2074550002 cites W244776692 @default.
• W2074550002 cites W2509770496 @default.
• W2074550002 cites W255299013 @default.
• W2074550002 cites W4242246035 @default.
• W2074550002 cites W4252374283 @default.
• W2074550002 cites W58289321 @default.
• W2074550002 doi "https://doi.org/10.1016/s0090-4295(98)00492-0" @default.
• W2074550002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9886580" @default.
• W2074550002 hasPublicationYear "1999" @default.
• W2074550002 type Work @default.
• W2074550002 sameAs 2074550002 @default.
• W2074550002 citedByCount "230" @default.
• W2074550002 countsByYear W20745500022012 @default.
• W2074550002 countsByYear W20745500022013 @default.
• W2074550002 countsByYear W20745500022014 @default.
• W2074550002 countsByYear W20745500022015 @default.
• W2074550002 countsByYear W20745500022016 @default.
• W2074550002 countsByYear W20745500022017 @default.
• W2074550002 countsByYear W20745500022018 @default.
• W2074550002 countsByYear W20745500022019 @default.
• W2074550002 countsByYear W20745500022020 @default.
• W2074550002 countsByYear W20745500022021 @default.
• W2074550002 countsByYear W20745500022022 @default.
• W2074550002 crossrefType "journal-article" @default.
• W2074550002 hasAuthorship W2074550002A5004249940 @default.
• W2074550002 hasAuthorship W2074550002A5007566100 @default.
• W2074550002 hasAuthorship W2074550002A5009179279 @default.
• W2074550002 hasAuthorship W2074550002A5014554150 @default.
• W2074550002 hasAuthorship W2074550002A5030172187 @default.
• W2074550002 hasAuthorship W2074550002A5031800910 @default.
• W2074550002 hasAuthorship W2074550002A5037441256 @default.
• W2074550002 hasAuthorship W2074550002A5047562050 @default.
• W2074550002 hasAuthorship W2074550002A5079008626 @default.
• W2074550002 hasConcept C121608353 @default.
• W2074550002 hasConcept C126322002 @default.
• W2074550002 hasConcept C126894567 @default.
• W2074550002 hasConcept C141071460 @default.
• W2074550002 hasConcept C2776235491 @default.
• W2074550002 hasConcept C2777416452 @default.
• W2074550002 hasConcept C2780192828 @default.
• W2074550002 hasConcept C2781406297 @default.
• W2074550002 hasConcept C44249647 @default.

• next